Bret Campbell is a partner in the Business Fraud and Complex Litigation Group in the Washington, D.C. office. Bret represents clients in a broad range of complex criminal, regulatory, and civil litigation matters involving international corruption and the Foreign Corrupt Practices Act, as well as securities, healthcare, accounting, and commercial fraud. He has extensive experience managing internal corporate investigations and cross-border criminal and regulatory matters, often in proceedings before the U.S. Department of Justice and the Securities and Exchange Commission. Other civil litigation experience includes representing clients in federal trial and appellate courts in matters involving contractual disputes, fraud, insurance coverage, employment issues, intellectual property rights and antitrust claims.
In addition to his litigation practice, Bret conducts FCPA and regulatory compliance due diligence reviews in connection with mergers, acquisitions, and other complex corporate transactions. He has directed numerous global due diligence reviews of proposed investments and business combinations in industries and jurisdictions presenting significant risks of corruption and fraud.
Bret also advises clients on corporate governance issues and on the implementation of compliance codes. He helps companies assess risks in their international operations, and counsels on the development and implementation of policies, procedures, and systems designed to prevent and detect potential violations of law. Bret regularly provides training on FCPA and related issues to his clients' legal, compliance and internal audit departments.
His clients include U.S. and foreign companies and individuals in the pharmaceutical, energy, medical device, telecommunications, financial services, defense, computer software, and aerospace industries. Recent engagements include litigation and internal investigations involving activities in Western and Eastern Europe (including Russia), Asia, Africa, the Middle East, Latin America and South America.
Bret writes and speaks frequently on regulatory, criminal law, and compliance issues, and has served as a faculty member of Seton Hall Law School's Healthcare Compliance Certification Program. He has spoken at events for the American Conference Institute, the Pharmaceutical Compliance Congress and Best Practices Forum, the Practising Law Institute, the Society of Corporate Compliance and Ethics, the Pharmaceutical Internal Audit Forum, and has co-chaired the American Conference Institute's annual conference on FCPA & Anti-Corruption for the Life Sciences Industry.
He received a B.A., with honors, in 1989 from Hobart College, and a J.D., cum laude, in 1994 from Vermont Law School. Bret is admitted to practice in the District of Columbia, the State of New York, and the U.S. District Court for the District of Columbia.